Post-exercise Therapeutic Modalities on Functional Performance, Muscle Damage and Oxidative Stress of CrossFit® Athletes

November 5, 2024 updated by: Ernesto Cesar Pinto Leal Junior, University of Nove de Julho

Crossfit® is a training modality that consists in functional movements, constantly varied and executed at high intensity. Both training sessions and competitions involve physically demanding activities, which in addition to being performed at very high intensity also involves the aerobic metabolism pathway. These characteristics led to very high metabolic and muscular stress, as well as decrease in physical performance immediately after competitions and training sessions. The cumulative effects of the metabolic and muscular stress can be a precursor of injuries. Studies using different therapeutic modalities aiming to improve post-exercise recovery are needed in order to tackle this issue.

Oxidative stress induced by exercise has been a research field in constant growth, due to its relationship with the processes of fatigue, decreased production of muscle strength, and its ability to cause damage to the cell.

To the date there are no studies comparing the effects of different therapeutic modalities applied after an exercise session on functional performance, muscle damage, and oxidative stress in an exercise modality such as Crossfit®.

Therefore, the aim of this project is to assess and compare the effects of different therapeutic modalities on functional performance, muscle damage, and oxidative stress of Crossfit® athletes.

Study Overview

Detailed Description

A randomized, crossover, controlled trial will be carried out.

All volunteers will be allocated to four interventions, and the order of the interventions will be randomized.

The outcomes will be assessed at baseline (prior to the Workout of the Day - WOD), and in different timepoints after the WOD.

The WOD will be consisted in finishing as quickly as possible a sequence of three exercises (Calories in Assault AirBike®, Hang Squat Clean and Box Jump Over), in a well-known series model for the athletes, without rest.

The investigators will analyze functional performance, biochemical markers of muscle damage and oxidative stress, the ratings of perceived exertion, and the volunteers satisfaction with the interventions.

All data will be analyzed both in their absolute values and in relation to their percentage variation from the values obtained in the pre-WOD (baseline) assessments.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • São Paulo, SP, Brazil, 01504-001
        • Laboratory of Phototherapy and Innovative Technologies in Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: - Crossfit® amateur male athletes; - Do not present a history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study; - Are not using pharmacological agents; - Athletes should have been practicing the sport for at least 1 year; - Voluntarily commit to participate in all stages of the study.

Exclusion Criteria: - Present musculoskeletal or joint injuries during data collection; - Present history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control
Passive recovery for 30 minutes
Volunteers laid in supine position resting for 30 minutes.
Experimental: PBMT-sMF
Photobiomodulation therapy combined with static magnetic field, with a total treatment duration lasting for around 30 minutes.
PBMT-sMF applied in the lower limbs with different doses per muscle group.
Active Comparator: Shock wave
Shock wave therapy applied for 30 minutes.
Shock wave therapy applied in the lower limbs for 30 minutes.
Active Comparator: Pneumatic compression
Pneumatic compression applied for 30 minutes.
Pneumatic compression applied in the lower limbs for 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional performance
Time Frame: 1 hour after WOD (workout of the day).
The functional performance will be assessed through the countermovement jump (CMJ) test.
1 hour after WOD (workout of the day).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participants' perceived exercise intensity
Time Frame: 1 minute after WOD (workout of the day), 1 minute post-treatment/intervention, 1 hour, 24 hours and 48 hours after WOD.
The perception of exercise intensity will be assessed through a 0-100 Ratings of Perceived Exertion Scale: in this scale lower score, means lower degree of fatigue and higher score, means higher degree of fatigue.
1 minute after WOD (workout of the day), 1 minute post-treatment/intervention, 1 hour, 24 hours and 48 hours after WOD.
Change in functional performance
Time Frame: 24 hours and 48 hours after WOD (workout of the day)
The functional performance will be assessed through the countermovement jump (CMJ) test.
24 hours and 48 hours after WOD (workout of the day)
Change in the activity of lactate dehydrogenase (LDH)
Time Frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).
The activity of LDH will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.
1 hour, 24 hours and 48 hours after WOD (workout of the day).
Change in thiobarbituric acid (TBARS)
Time Frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).
TBARS will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.
1 hour, 24 hours and 48 hours after WOD (workout of the day).
Change in carbonylated proteins
Time Frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).
Carbonylated proteins will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.
1 hour, 24 hours and 48 hours after WOD (workout of the day).
Change in catalase (CAT) activity
Time Frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).
CAT activity will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.
1 hour, 24 hours and 48 hours after WOD (workout of the day).
Change in superoxide dismutase (SOD) activity
Time Frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).
SOD activity will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.
1 hour, 24 hours and 48 hours after WOD (workout of the day).
Participants' satisfaction regarding the interventions
Time Frame: 48 hours after WOD (workout of the day).
The participants satisfaction regarding the interventions will be assessed through the LIKERT scale.
48 hours after WOD (workout of the day).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ernesto Cesar Pinto Leal Junior, Ph.D., M.Sc., PT., Nove de Julho University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2024

Primary Completion (Actual)

November 3, 2024

Study Completion (Actual)

November 3, 2024

Study Registration Dates

First Submitted

October 3, 2024

First Submitted That Met QC Criteria

October 3, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

November 6, 2024

Last Update Submitted That Met QC Criteria

November 5, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 3.997.120

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be shared upon request addressed to the principal investigator.

IPD Sharing Time Frame

The data will become available six months after the manuscript publication for five years after that.

IPD Sharing Access Criteria

All IPD that underlie results in a publication will be available on reasonable request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Recovery

Clinical Trials on Passive recovery

Subscribe